From chemistry curiosity to wartime staple
Amphetamine was first synthesized in 1887; methamphetamine, the more potent, faster-acting relative, followed in 1893 and was refined into its crystalline smokable form in 1919 by Japanese chemist Akira Ogata. Its wartime use across multiple countries in the 1940s set up the first real epidemic: after the war, large military stockpiles of methamphetamine entered the civilian market in Japan, triggering that country's first documented meth epidemic in the 1950s. In the U.S., meth and related amphetamines were legally prescribed through the 1950s and '60s for weight loss, depression, and fatigue — a legitimate medical framing that, in hindsight, undersold the drug's addiction potential considerably.
Bikers, rural labs, and a law that actually worked — for a while
Meth production and distribution in the U.S. became associated with outlaw motorcycle clubs from the 1960s through the 1980s (sometimes called "crank" from its early smuggling method), then shifted dramatically in the 1990s and 2000s toward small-scale rural production — the "meth lab" era that became a defining, if stereotyped, image of the rural Midwest drug crisis and later a cultural touchstone through shows like Breaking Bad. This particular form of the problem had an identifiable choke point: small-batch domestic production relied heavily on pseudoephedrine, a common over-the-counter decongestant ingredient. The Combat Methamphetamine Epidemic Act of 2005, which restricted retail pseudoephedrine sales, substantially cut domestic small-lab production — a genuinely rare example of a specific drug-policy intervention producing a measurable, specific result.
The supply shifted, not the demand
Restricting the precursor chemical didn't end meth's presence — it moved production overseas and to large-scale, cartel-run industrial operations, mostly in Mexico, capable of producing meth more cheaply, more potently, and more consistently than the old small domestic labs ever could. Combined with the ongoing opioid crisis, researchers now describe the current landscape as a "fourth wave" of America's overlapping drug crises, driven substantially by stimulants (meth and cocaine) alongside opioids rather than opioids alone. Roughly 2 million U.S. adults reported past-year methamphetamine use recently — up 43% from four years earlier — even as overall overdose numbers (including a modest recent decline in psychostimulant-involved deaths specifically) have started to improve.
What the drug actually does, and the real dangers
Methamphetamine is a powerful, long-acting stimulant — effects from a single dose can last many hours longer than cocaine's, driving longer binges and more profound sleep deprivation. The real dangers:
Severe cardiovascular strain. Like cocaine, meth significantly raises heart rate and blood pressure and constricts blood vessels, creating real risk of heart attack, stroke, and, with chronic heavy use, lasting cardiovascular damage.
Meth-induced psychosis. Heavy or prolonged use is strongly associated with a genuine psychotic state — paranoia, hallucinations, delusions — that can persist for weeks after use stops, and in some cases longer, distinct from and generally more severe and longer-lasting than the psychosis risk associated with the psychedelics covered elsewhere in this category.
"Meth mouth." The severe dental damage associated with chronic meth use is real and well-documented, though it's an indirect effect rather than a direct chemical attack on teeth: it results from the combination of dry mouth (reduced saliva, which normally protects teeth), teeth grinding, poor oral hygiene during binges, and frequent consumption of sugary drinks to combat dry mouth — a cluster of behavioral and physiological effects that together cause rapid, severe tooth decay.
Profound addiction potential and cognitive effects. Meth is strongly and rapidly addictive, and chronic heavy use is associated with real, measurable cognitive impairment, alongside extreme weight loss and compulsive skin-picking (a common symptom of meth-associated formication, the sensation of insects crawling under the skin).
Fentanyl cross-contamination. As with cocaine, illicit methamphetamine can be contaminated with fentanyl, adding a genuine opioid overdose risk to a drug whose users may have no history with or tolerance for opioids at all.
The 2005 pseudoephedrine law is one of the few clean success stories in American drug policy — and also a clear lesson in how supply-side restrictions reshape a market rather than eliminate it, since industrial cartel production simply replaced the small domestic labs it shut down.
Try this
If methamphetamine touches your life or someone else's, know that meth-induced psychosis, while frightening, is generally treatable and often resolves with abstinence and medical support — it's a genuine psychiatric emergency worth treating as one, not a permanent condition to assume is untreatable.
The takeaway
Methamphetamine, refined into its modern form in 1919 and used by multiple militaries during World War II to fight fatigue, moved from legitimate 1950s-60s medical prescribing into a series of distinct American drug crises — biker-associated distribution, the rural "meth lab" era, and today's cartel-supplied "fourth wave," now intertwined with the broader opioid crisis and its own fentanyl contamination risk. A 2005 law restricting a key precursor chemical genuinely cut domestic small-lab production, but overseas industrial production simply replaced it. Its core dangers are severe cardiovascular strain, meth-induced psychosis that can persist for weeks, "meth mouth" from a cluster of indirect physiological effects, and profound addiction potential.
Try this: if meth-induced psychosis affects someone you know, treat it as the genuine, generally treatable psychiatric emergency it is — not an assumed-permanent condition.
Sources & Further Reading
Sources
- WWII-era military stimulant use (including Pervitin) and postwar Japanese epidemic history reflect documented pharmacological and military history.
- U.S. meth production history, including the biker-distribution era and rural lab era, and the 2005 Combat Methamphetamine Epidemic Act's effect on domestic production, reflect documented U.S. drug-policy history.
- The "fourth wave" framing and current use statistics reflect current 2026 public-health and addiction-research reporting.
- Meth-induced psychosis, cardiovascular risk, and "meth mouth" mechanisms reflect standard clinical and dental literature.
Go deeper
- 🌐 Search "Combat Methamphetamine Epidemic Act 2005 effects" for the specific policy case study
- 🌐 SAMHSA.gov — treatment resources for stimulant use disorder
- 🌐 Related piece in this library: Cocaine, this category, for the closest pharmacological comparison